Jung-Jin Seo
Presidente presso CELLTRION HEALTHCARE CO., LTD.
Patrimonio netto: 7 599 M $ in data 30/06/2024
Profilo
Attualmente, Jung-Jin Seo occupa la posizione di Presidente di Celltrion Healthcare Co., Ltd., Presidente di Celltrion, Inc. (una consociata di Celltrion, Inc.) e amministratore delegato di Celltrion Holdings Co. Il signor Seo è anche nel consiglio di amministrazione della Korea National Opera.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CELLTRION, INC.
27.66% | 02/07/2024 | 60 012 150 ( 27.66% ) | 7 599 M $ | 30/06/2024 |
Posizioni attive di Jung-Jin Seo
| Società | Posizione | Inizio |
|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Presidente | - |
| CELLTRION PHARM, INC. | Presidente | 23/01/2009 |
| CELLTRION, INC. | Presidente | - |
Korea National Opera
 Korea National Opera Movies/EntertainmentConsumer Services Korea National Opera presents live entertainment productions. Yong-Man Park has been the CEO of the South Korean company since 2016. | Direttore/Membro del Consiglio | 27/01/2020 |
Precedenti posizioni note di Jung-Jin Seo
| Società | Posizione | Fine |
|---|---|---|
Celltrion Holdings Co., Ltd.
 Celltrion Holdings Co., Ltd. Movies/EntertainmentConsumer Services Celltrion Holdings Co., Ltd. produces broadcast programs and offers system integration services. The company was founded on November 25, 2010 and is headquartered in Incheon, South Korea. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CELLTRION PHARM, INC. | Health Technology |
| CELLTRION, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Celltrion Healthcare Co., Ltd.
 Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Holdings Co., Ltd.
Celltrion Holdings Co., Ltd. Movies/EntertainmentConsumer Services Celltrion Holdings Co., Ltd. produces broadcast programs and offers system integration services. The company was founded on November 25, 2010 and is headquartered in Incheon, South Korea. | Consumer Services |
Korea National Opera
Korea National Opera Movies/EntertainmentConsumer Services Korea National Opera presents live entertainment productions. Yong-Man Park has been the CEO of the South Korean company since 2016. | Consumer Services |
- Borsa valori
- Insiders
- Jung-Jin Seo
